Close Menu

On the Wall Street Journal health blog, Jacob Goldstein discusses the "battle" for the diagnostic company Ventana -- Roche made a hostile bid for the company earlier this year. Goldstein reports that Roche's CEO, Franz Hume, has been saying that hedge funds have bought out the leading shareholders but that Roche's $3 billion offer will eventually go through.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.